Publications

Peer-Reviewed Publications

  1. Samorodnitsky, S., Lock, E. F., Kruk, M., Morris, A., Leung, J. M., Kunisaki, K. M., Griffin, T. J., & Wendt, C. H. (2022) Lung Proteome and Metabolome Endotype in HIV-Associated Obstructive Lung Disease in Case-Control Study. European Respiratory Journal Open Research. In press.

  2. Wendt, C. H., Samorodnitsky, S., Lock, E. F., Kruk, M., Morris, A., Leung, J. M., Kunisaki, K. M., & Griffin, T. J. (2022). Lung and Plasma Metabolome in HIV-Associated Obstructive Lung Disease. JAIDS Journal of Acquired Immune Deficiency Syndromes, 91(3), 312-318.

  3. Samorodnitsky, S., Hoadley, K. A., & Lock, E. F. (2022). A hierarchical spike-and-slab model for pan-cancer survival using pan-omic data. BMC bioinformatics, 23(1), 1-21.

  4. Samorodnitsky, S., Hoadley, K. A., & Lock, E. F. (2020). A Pan-Cancer and Polygenic Bayesian Hierarchical Model for the Effect of Somatic Mutations on Survival. Cancer informatics, 19, 1176935120907399.

Manuscripts Under Review

  1. Samorodnitsky, S., Wendt, C. H., Lock, E. F. (2022) Bayesian Simultaneous Factorization and Prediction Using Multi-Omic Data. arXiv preprint arXiv:2211.16403

  2. Castro-Pearson, S.*, Samorodnitsky, S.* Yang, K.*, Lotfi-Emran, S., Ingraham, N. E., Bramante, C., Greising, S., Jones, E. K., Wacker, D., Puskarich, M., Lusczek, E., Safo, S., & Tignanelli, C. J. (2022). Proteomic pathways associated with developing severe disease for patients with COVID-19: a biologic analysis of data from two multicenter randomized controlled trials encompassing 13 U.S. hospitals

  3. MacDonald, D. M., Samorodnitsky, S., Wendt, C. H., Baker, J. V., Collins, G., Lock, E. F., Plettenberg, A., Poongulali, S., Winston, A., Wood, R., & Kunisaki, K. M. (2021). Biomarkers of Rapid Lung Function Decline in Well-Controlled HIV and Untreated HIV: A Secondary Analysis of Inflammation, Coagulation, and Pneuomoproteins in the START Pulmonary Substudy

*Authors contributed equally.